David A Morrow Selected Research

Troponin T (Troponin T1)

12/2022	Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT.
1/2022	Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
11/2021	A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
1/2021	Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
1/2020	Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
1/2019	Biomarker of Collagen Turnover (C-Terminal Telopeptide) and Prognosis in Patients With Non- ST -Elevation Acute Coronary Syndromes.
1/2019	Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trial.
12/2016	Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial.
1/2016	Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
9/2011	Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Morrow Research Topics

Disease

146	Myocardial Infarction 02/2024 - 06/2002
135	Acute Coronary Syndrome 01/2023 - 02/2002
81	Heart Failure 03/2024 - 05/2004
57	ST Elevation Myocardial Infarction 01/2022 - 07/2002
45	Hemorrhage 01/2024 - 04/2005
44	Stroke (Strokes) 01/2024 - 08/2006
43	Ischemia 01/2022 - 04/2003
27	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 04/2002
27	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2002
26	Atherosclerosis 08/2022 - 02/2003
25	Thrombosis (Thrombus) 01/2023 - 07/2002
19	Cardiogenic Shock 04/2024 - 09/2010
18	Inflammation (Inflammations) 07/2023 - 02/2003
18	Peripheral Arterial Disease 10/2021 - 09/2009
17	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2002
17	Unstable Angina 02/2017 - 06/2002
16	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018 - 07/2002
15	Type 2 Diabetes Mellitus (MODY) 10/2023 - 10/2014
15	Hypertension (High Blood Pressure) 01/2023 - 02/2003
14	Shock 01/2024 - 01/2019
14	COVID-19 03/2023 - 01/2020
13	Atrial Fibrillation 01/2024 - 01/2015
13	Ischemic Stroke 01/2023 - 09/2009
13	Diabetes Mellitus 11/2021 - 04/2006
11	Infarction (Infarctions) 01/2022 - 07/2002
10	Infections 01/2020 - 10/2005
9	Heart Arrest (Cardiac Arrest) 11/2023 - 01/2019
8	Necrosis 01/2016 - 01/2003
7	Chronic Renal Insufficiency 01/2023 - 04/2006
7	Critical Illness (Critically Ill) 01/2023 - 01/2019
7	Respiratory Insufficiency (Respiratory Failure) 08/2022 - 01/2018
7	Coronary Disease (Coronary Heart Disease) 09/2016 - 02/2003
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2014 - 10/2005
6	Chest Pain (Chest Pains) 10/2023 - 09/2013
6	Transient Ischemic Attack 01/2019 - 12/2014
5	Vascular Diseases (Vascular Disease) 01/2023 - 08/2003
5	Heart Diseases (Heart Disease) 08/2022 - 12/2010
5	Ventricular Tachycardia 01/2021 - 08/2010
4	Hypotension (Low Blood Pressure) 03/2024 - 01/2019
4	Cardiac Arrhythmias (Arrythmia) 03/2024 - 04/2007
4	Pathologic Constriction (Stenosis) 03/2024 - 08/2004
4	Embolism (Embolus) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

79	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2002
39	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2023 - 02/2002
35	TroponinIBA 10/2023 - 07/2002
31	C-Reactive ProteinIBA 01/2022 - 04/2002
26	vorapaxarIBA 08/2022 - 09/2009
24	Ranolazine FDA Link 01/2021 - 06/2006
23	Neurofibromin 2 (Merlin)IBA 01/2021 - 06/2006
22	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 11/2005
22	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 06/2002
21	Troponin IIBA 01/2021 - 04/2002
18	Natriuretic PeptidesIBA 12/2023 - 01/2003
17	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 02/2005
16	Troponin T (Troponin T1)IBA 12/2022 - 07/2002
14	sacubitril and valsartan sodium hydrate drug combinationIBA 03/2024 - 01/2018
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 10/2005
14	Clopidogrel (Plavix)FDA Link 11/2022 - 12/2005
13	AnticoagulantsIBA 01/2024 - 03/2005
12	Tirofiban (Aggrastat)FDA Link 09/2008 - 07/2002
11	Enalapril FDA LinkGeneric 03/2024 - 01/2018
11	omega-Chloroacetophenone (Mace)IBA 01/2023 - 06/2007
11	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2005
11	Atorvastatin (Lipitor)FDA Link 06/2011 - 05/2005
11	Pravastatin (Pravachol)FDA LinkGeneric 06/2011 - 05/2005
10	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
10	Glycoproteins (Glycoprotein)IBA 01/2014 - 11/2002
9	CreatinineIBA 01/2024 - 11/2003
8	dapagliflozinIBA 10/2023 - 01/2021
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2008
7	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 06/2015
7	Growth Differentiation Factor 15IBA 01/2023 - 10/2010
7	Thrombin FDA Link 10/2019 - 04/2005
7	AntithrombinsIBA 09/2010 - 08/2004
6	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 06/2006
5	trans-crotonin (CTN)IBA 10/2023 - 11/2013
5	CytokinesIBA 07/2023 - 02/2006
5	Valsartan (Vals)FDA Link 01/2023 - 08/2010
5	Thromboplastin (Tissue Factor)IBA 01/2023 - 04/2005
5	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2022 - 09/2009
5	oxidized low density lipoproteinIBA 01/2022 - 05/2005
5	saxagliptin FDA Link 11/2021 - 10/2014
5	TicagrelorIBA 11/2020 - 09/2016
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
5	alogliptinIBA 01/2018 - 01/2017
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2018 - 04/2006
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2014 - 11/2005
5	N(2)-(3-trifluoromethylphenyl)guanineIBA 11/2011 - 07/2002
5	CalciumIBA 10/2007 - 11/2005
4	Vitamin K FDA Link 01/2024 - 06/2015
4	Hemoglobins (Hemoglobin)IBA 10/2023 - 04/2005

Therapy/Procedure

89	Therapeutics 10/2023 - 07/2002
25	Percutaneous Coronary Intervention 01/2022 - 11/2003
21	Critical Care (Surgical Intensive Care) 04/2024 - 01/2015
19	Secondary Prevention 10/2021 - 09/2009
11	Thrombolytic Therapy 09/2010 - 11/2004
6	Extracorporeal Membrane Oxygenation 11/2023 - 01/2018
6	Patient Readmission 01/2021 - 02/2004
6	Stents 01/2020 - 05/2006
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 09/2008